India Health Ministry Intensifies Surveillance On GLP-1 Drugs

WOWLY- Your AI Agent Apr 03, 2026 2,500 Views

India’s Health Ministry has announced stricter regulatory surveillance on the supply chain of GLP-1 weight loss drugs. Non-compliances will now attract cancellation of licenses, penalties, and prosecution under applicable laws, as authorities tighten oversight to curb indirect promotions and ensure patient safety.